Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Wearable Devices Ltd.
13G/A
Amendment 2
WLDS · M97838409
|
4.99% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Voyager Therapeutics, Inc.
13G/A
Amendment 9
VYGR · 92915B106
|
5.6% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 5.6% | ||||
| Steven Boyd | 5.6% | ||||
|
Vivos Therapeutics, Inc.
13G/A
Amendment 1
VVOS · 92859E207
|
4.99% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Verastem, Inc.
13G/A
Amendment 2
VSTM · 92337C203
|
7.8% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 7.8% | ||||
| Steven Boyd | 7.8% | ||||
|
VSee Health, Inc.
13G/A
Amendment 2
VSEE · 92919Y102
|
7.3% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 7.3% | ||||
| Steven Boyd | 7.3% | ||||
|
Travere Therapeutics, Inc.
13G/A
Amendment 1
TVTX · 89422G107
|
1.7% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 1.7% | ||||
| Steven Boyd | 1.7% | ||||
|
Trevena, Inc.
13G
TRVN · 89532E307
|
9.9% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 9.9% | ||||
| Steven Boyd | 9.9% | ||||
|
Tenon Medical, Inc.
13G
TNON · 88066N303
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Treace Medical Concepts, Inc.
13G/A
Amendment 7
TMCI · 89455T109
|
9.8% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 9.8% | ||||
| Steven Boyd | 9.8% | ||||
|
Stryve Foods, Inc.
13G/A
Amendment 4
SNAX · 863685202
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Sangamo Therapeutics, Inc.
13G/A
Amendment 1
SGMOQ · 800677106
|
9.4% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 9.4% | ||||
| Steven Boyd | 9.4% | ||||
|
Rapid Micro Biosystems, Inc.
13G
RPID · 75340L104
|
7.3% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 7.3% | ||||
| Steven Boyd | 7.3% | ||||
|
Arcadia Biosciences, Inc.
13G/A
Amendment 1
RKDA · 039014303
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Rigel Pharmaceuticals, Inc.
13G/A
Amendment 1
RIGL · 766559702
|
9.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 9.0% | ||||
| Steven Boyd | 9.0% | ||||
|
Revelation Biosciences, Inc.
13G/A
Amendment 1
REVB · 76135L804
|
4.99% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Powercompute, Inc.
13G/A
Amendment 7
PWCM · 502074602
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
The Olb Group, Inc.
13G/A
Amendment 1
OLB · 67086U406
|
8.6% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 8.6% | ||||
| Steven Boyd | 8.6% | ||||
|
Orthofix Medical Inc.
13G/A
Amendment 8
OFIX · 68752M108
|
8.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 8.0% | ||||
| Steven Boyd | 8.0% | ||||
|
Nuwellis, Inc.
13G/A
Amendment 1
NUWE · 67113Y801
|
4.99% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Macrogenics, Inc.
13G/A
Amendment 8
MGNX · 556099109
|
7.9% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 7.9% | ||||
| Steven Boyd | 7.9% | ||||
|
Li-Cycle Holdings Corp.
13G/A
Amendment 2
LICYQ · 50202P204
|
7.6% |
8/14/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 7.6% | ||||
| Steven Boyd | 7.6% | ||||
|
Kyntra Bio, Inc.
13G/A
Amendment 8
KYNB · 31572Q881
|
9.9% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 9.9% | ||||
| Steven Boyd | 9.9% | ||||
|
Invo Fertility, Inc.
13G/A
Amendment 2
IVF · 44984F880
|
4.99% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Ironwood Pharmaceuticals, Inc.
13G/A
Amendment 7
IRWD · 46333X108
|
8.4% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 8.4% | ||||
| Steven Boyd | 8.4% | ||||
|
Inuvo, Inc.
13G
INUV · 46122W303
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Intelligent Bio Solutions Inc.
13G/A
Amendment 1
INBS · 36151G709
|
5.9% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 5.9% | ||||
| Steven Boyd | 5.9% | ||||
|
Imunon, Inc.
13G/A
Amendment 2
IMNN · 15117N701
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Icecure Medical Ltd.
13G
ICCM · M53071201
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Geovax Labs, Inc.
13G/A
Amendment 4
GOVX · 373678705
|
4.99% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Global Interactive Technologies, Inc.
13G
GITS · 411292204
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Generation Income Properties, Inc.
13G
GIPR · 37149D402
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
FibroBiologics, Inc.
13G
FBLG · 31573L204
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Evogene Ltd.
13G/A
Amendment 1
EVGN · M4119S187
|
4.99% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Estrella Immunopharma, Inc.
13G/A
Amendment 1
ESLA · 297584104
|
4.99% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Enveric Biosciences, Inc.
13G
ENVB · 29405E505
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Dogwood Therapeutics, Inc.
13G/A
Amendment 1
DWTX · 92829J203
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Decoy Therapeutics Inc.
13G
DCOY · 79400X602
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Citius Oncology, Inc.
13G/A
Amendment 4
CTOR · 17331Y109
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
CervoMed Inc.
13G
CRVO · 15713L109
|
9.5% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 9.5% | ||||
| Steven Boyd | 9.5% | ||||
|
Co-Diagnostics, Inc.
13G
CODX · 189763204
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Calidi Biotherapeutics, Inc.
13G/A
Amendment 1
CLDI · 320703507
|
4.99% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Change Agents Corporation
13G
CHGA · 05344R302
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
CalciMedica, Inc.
13G
CALC · 38942Q202
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
BioXcel Therapeutics, Inc.
13G/A
Amendment 1
BTAIQ · 09075P204
|
4.99% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Bluejay Diagnostics, Inc.
13G
BJDX · 095633608
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Biodexa Pharmaceuticals Plc
13G/A
Amendment 2
BDRX · 59564R872
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Bicycle Therapeutics plc
13G/A
Amendment 2
BCYC · 088786108
|
6.7% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 6.7% | ||||
| Steven Boyd | 6.7% | ||||
|
Autolus Therapeutics plc
13G/A
Amendment 3
AUTL · 05280R100
|
5.6% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 5.6% | ||||
| Steven Boyd | 5.6% | ||||
|
Artelo Biosciences, Inc.
13G/A
Amendment 1
ARTL · 04301G706
|
0% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 0% | ||||
| Steven Boyd | 0% | ||||
|
Aridis Pharmaceuticals, Inc.
13G/A
Amendment 9
ARDS · 040334104
|
11.4% |
8/14/2026
Event 6/30/2026
|
|||
| Armistice Capital, LLC | 11.4% | ||||
| Steven Boyd | 11.4% | ||||
|
Revelation Biosciences, Inc.
13G
REVB · 76135L804
|
7.8% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 7.8% | ||||
| Steven Boyd | 7.8% | ||||
|
Rigel Pharmaceuticals, Inc.
13G
RIGL · 766559702
|
6.9% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 6.9% | ||||
| Steven Boyd | 6.9% | ||||
|
Rekor Systems, Inc.
13G/A
Amendment 1
REKR · 759419104
|
2.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 2.0% | ||||
| Steven Boyd | 2.0% | ||||
|
The Olb Group, Inc.
13G
OLB · 67086U406
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Orthofix Medical Inc.
13G/A
Amendment 7
OFIX · 68752M108
|
6.7% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 6.7% | ||||
| Steven Boyd | 6.7% | ||||
|
Nuwellis, Inc.
13G
NUWE · 67113Y702
|
7.1% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 7.1% | ||||
| Steven Boyd | 7.1% | ||||
|
Macrogenics, Inc.
13G/A
Amendment 7
MGNX · 556099109
|
9.5% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 9.5% | ||||
| Steven Boyd | 9.5% | ||||
|
Arcadia Biosciences, Inc.
13G
RKDA · 039014303
|
7.8% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 7.8% | ||||
| Steven Boyd | 7.8% | ||||
|
LM Funding America, Inc.
13G/A
Amendment 6
LMFA · 502074503
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Li-Cycle Holdings Corp.
13G/A
Amendment 1
LICYQ · 50202P204
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Sangamo Therapeutics, Inc.
13G
SGMOQ · 800677106
|
9.8% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 9.8% | ||||
| Steven Boyd | 9.8% | ||||
|
Kyntra Bio, Inc.
13G/A
Amendment 7
KYNB · 31572Q881
|
9.9% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 9.9% | ||||
| Steven Boyd | 9.9% | ||||
|
Kura Oncology, Inc.
13G/A
Amendment 5
KURA · 50127T109
|
4.2% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 4.2% | ||||
| Steven Boyd | 4.2% | ||||
|
Invo Fertility, Inc.
13G/A
Amendment 1
IVF · 44984F880
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Stryve Foods, Inc.
13G/A
Amendment 3
SNAX · 863685202
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Ironwood Pharmaceuticals, Inc.
13G/A
Amendment 6
IRWD · 46333X108
|
9.2% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 9.2% | ||||
| Steven Boyd | 9.2% | ||||
|
Intelligent Bio Solutions Inc.
13G
INBS · 36151G709
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Sobr Safe, Inc.
13G/A
Amendment 1
SOBR · 833592405
|
4.99% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Imunon, Inc.
13G/A
Amendment 1
IMNN · 15117N701
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Inspira Technologies Oxy B.H.N. Ltd.
13G
QTEX · M53637100
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Presidio Property Trust, Inc.
13G/A
Amendment 2
SQFT · 74102L501
|
4.99% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
HCW Biologics Inc.
13G/A
Amendment 1
HCWB · 40423R204
|
4.99% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Geovax Labs, Inc.
13G/A
Amendment 3
GOVX · 373678705
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Treace Medical Concepts, Inc.
13G/A
Amendment 6
TMCI · 89455T109
|
9.9% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 9.9% | ||||
| Steven Boyd | 9.9% | ||||
|
Globus Maritime Limited
13G/A
Amendment 4
GLBS · Y27265126
|
4.99% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Glucotrack, Inc.
13G/A
Amendment 1
GCTK · 45824Q804
|
4.99% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Travere Therapeutics, Inc.
13G
TVTX · 89422G107
|
5.3% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 5.3% | ||||
| Steven Boyd | 5.3% | ||||
|
Evogene Ltd.
13G
EVGN · M4119S187
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Estrella Immunopharma, Inc.
13G
ESLA · 297584104
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Virax Biolabs Group Limited
13G/A
Amendment 1
VRAX · G9495L125
|
4.99% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Ekso Bionics Holdings, Inc.
13G/A
Amendment 4
EKSO · 282644400
|
4.99% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Dogwood Therapeutics, Inc.
13G
DWTX · 92829J203
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
VSee Health, Inc.
13G/A
Amendment 1
VSEE · 92919Y102
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Cycurion, Inc.
13G/A
Amendment 1
CYCU · 95758L305
|
4.99% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Citius Oncology, Inc.
13G/A
Amendment 3
CTOR · 17331Y109
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Curis, Inc.
13G/A
Amendment 3
CRIS · 231269309
|
4.99% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Calidi Biotherapeutics, Inc.
13G
CLDI · 320703408
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
BioXcel Therapeutics, Inc.
13G
BTAIQ · 09075P204
|
7.1% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 7.1% | ||||
| Steven Boyd | 7.1% | ||||
|
Bluejay Diagnostics, Inc.
13G/A
Amendment 1
BJDX · 095633608
|
4.99% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Verastem, Inc.
13G/A
Amendment 1
VSTM · 92337C203
|
5.2% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 5.2% | ||||
| Steven Boyd | 5.2% | ||||
|
Biodexa Pharmaceuticals Plc
13G/A
Amendment 1
BDRX · 59564R872
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Bicycle Therapeutics plc
13G/A
Amendment 1
BCYC · 088786108
|
6.8% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 6.8% | ||||
| Steven Boyd | 6.8% | ||||
|
Avanos Medical, Inc.
13G/A
Amendment 2
AVNS · 05350V106
|
4.3% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 4.3% | ||||
| Steven Boyd | 4.3% | ||||
|
Autolus Therapeutics plc
13G/A
Amendment 2
AUTL · 05280R100
|
5.9% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 5.9% | ||||
| Steven Boyd | 5.9% | ||||
|
Vivos Therapeutics, Inc.
13G
VVOS · 92859E207
|
8.3% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 8.3% | ||||
| Steven Boyd | 8.3% | ||||
|
Ascent Solar Technologies, Inc.
13G/A
Amendment 1
ASTI · 043635804
|
4.99% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 4.99% | ||||
| Steven Boyd | 4.99% | ||||
|
Artelo Biosciences, Inc.
13G
ARTL · 04301G706
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||
|
Voyager Therapeutics, Inc.
13G/A
Amendment 8
VYGR · 92915B106
|
5.9% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 5.9% | ||||
| Steven Boyd | 5.9% | ||||
|
Aridis Pharmaceuticals, Inc.
13G/A
Amendment 8
ARDS · 040334104
|
11.4% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 11.4% | ||||
| Steven Boyd | 11.4% | ||||
|
Avalon Globocare Corp.
13G
CHGA · 05344R302
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Armistice Capital, LLC | 10.0% | ||||
| Steven Boyd | 10.0% | ||||